Dave Smith

1.8k total citations
18 papers, 607 citations indexed

About

Dave Smith is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Dave Smith has authored 18 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 12 papers in Pediatrics, Perinatology and Child Health and 4 papers in Genetics. Recurrent topics in Dave Smith's work include Epilepsy research and treatment (13 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Glioma Diagnosis and Treatment (3 papers). Dave Smith is often cited by papers focused on Epilepsy research and treatment (13 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Glioma Diagnosis and Treatment (3 papers). Dave Smith collaborates with scholars based in United Kingdom and United States. Dave Smith's co-authors include Andrew Nicolson, David Chadwick, R E Appleton, John Paul Leach, Jane L. Hutton, P M Foy, Ian Williams, M D Shaw, P. Roberts and Alison Graham and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, British Journal of Clinical Pharmacology and Health Technology Assessment.

In The Last Decade

Dave Smith

17 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dave Smith United Kingdom 11 408 340 103 89 65 18 607
Philip H. Sheridan United States 11 227 0.6× 358 1.1× 12 0.1× 171 1.9× 48 0.7× 21 658
Jennifer Weiner United States 9 435 1.1× 428 1.3× 43 0.4× 33 0.4× 11 0.2× 22 699
Svetlana Dimova Belgium 11 210 0.5× 187 0.6× 12 0.1× 76 0.9× 46 0.7× 34 421
Marine Auffret France 13 37 0.1× 43 0.1× 143 1.4× 63 0.7× 46 0.7× 47 531
Betsy Ostrander United States 11 94 0.2× 182 0.5× 16 0.2× 11 0.1× 13 0.2× 24 875
Tanja Falter Germany 11 59 0.1× 27 0.1× 59 0.6× 15 0.2× 25 0.4× 26 384
Hassan H. Jamal United States 9 198 0.5× 33 0.1× 7 0.1× 33 0.4× 35 0.5× 17 562
Miranda Pans Belgium 10 244 0.6× 49 0.1× 20 0.2× 8 0.1× 55 0.8× 10 493
Elisabeth Hazard United States 8 333 0.8× 18 0.1× 22 0.2× 22 0.2× 12 0.2× 10 628
Kate Gelperin United States 11 89 0.2× 72 0.2× 29 0.3× 14 0.2× 11 0.2× 17 449

Countries citing papers authored by Dave Smith

Since Specialization
Citations

This map shows the geographic impact of Dave Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dave Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dave Smith more than expected).

Fields of papers citing papers by Dave Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dave Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dave Smith. The network helps show where Dave Smith may publish in the future.

Co-authorship network of co-authors of Dave Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Dave Smith. A scholar is included among the top collaborators of Dave Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dave Smith. Dave Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Marson, Anthony G, Girvan Burnside, Richard Appleton, et al.. (2021). Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Health Technology Assessment. 25(75). 1–134. 10 indexed citations
2.
3.
Marson, Anthony G, R E Appleton, G. Baker, et al.. (2007). A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technology Assessment. 11(37). iii–iv, ix. 83 indexed citations
4.
Smith, Dave, et al.. (2007). The impact of a citywide audit with educational intervention on the care of patients with epilepsy. Seizure. 17(3). 261–268. 13 indexed citations
5.
Smith, Dave, et al.. (2006). Counselling of women with epilepsy on anti-epileptic drugs: The value of nurse-led clinics. British Journal of Neuroscience Nursing. 2(7). 356–360. 1 indexed citations
6.
Leach, John Paul, et al.. (2005). Epilepsy in the UK: Misdiagnosis, mistreatment, and undertreatment?. Seizure. 14(7). 514–520. 107 indexed citations
7.
Lozsádi, Dora A., Gerd Peters, Helen Sadik, et al.. (2005). Prevention of osteoporosis in glucocorticoid-treated neurology patients. Clinical Neurology and Neurosurgery. 108(2). 157–162. 10 indexed citations
8.
Nicolson, Andrew, et al.. (2004). A comparison of adult onset and "classical" idiopathic generalised epilepsy.. PubMed. 75(1). 72–4. 27 indexed citations
9.
Hutchings, A., et al.. (2004). Inappropriate requests for serum anti-epileptic drug levels in hospital practice. QJM. 97(6). 337–341. 14 indexed citations
10.
Nicolson, Andrew, R E Appleton, David Chadwick, & Dave Smith. (2004). The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies.. PubMed. 75(1). 75–9. 111 indexed citations
11.
Smith, Dave. (2001). THE MANAGEMENT OF EPILEPSY. Journal of Neurology Neurosurgery & Psychiatry. 70(90002). 15ii–21. 11 indexed citations
12.
Smith, Dave, et al.. (2001). Requests for electroencephalography in a district general hospital: retrospective and prospective audit. BMJ. 322(7292). 954–957. 36 indexed citations
13.
Kitchen, Dianne & Dave Smith. (2001). Problems with phenytoin administration in neurology/neurosurgery ITU patients receiving enteral feeding. Seizure. 10(4). 265–268. 10 indexed citations
15.
Hutton, Jane L., Dave Smith, & David Chadwick. (1995). Prospective evaluation of a prognostic index for intrinsic supratentorial tumours.. Journal of Neurology Neurosurgery & Psychiatry. 59(1). 92–94. 1 indexed citations
16.
Hutton, Jane L., Dave Smith, P M Foy, et al.. (1992). Development of prognostic index for primary supratentorial intracerebral tumours.. Journal of Neurology Neurosurgery & Psychiatry. 55(4). 271–274. 12 indexed citations
17.
Pirmohamed, Munir, Alison Graham, P. Roberts, et al.. (1991). Carbamazepine‐hypersensitivity: assessment of clinical and in vitro chemical cross‐reactivity with phenytoin and oxcarbazepine.. British Journal of Clinical Pharmacology. 32(6). 741–749. 79 indexed citations
18.
Smith, Dave, Jane L. Hutton, P M Foy, et al.. (1991). The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management.. Journal of Neurology Neurosurgery & Psychiatry. 54(10). 915–920. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026